Key result
Hepatic GPR146 knockdown cuts macrophage lipid accumulation and shifts polarization from M1 to M2.
Why the study?
GPR146 is involved in lipid metabolism and atherosclerosis, but whether hepatic GPR146 exerts systemic metabolic effects that remotely modulate macrophage function remained unexplored.
Does hepatic GPR146 knockdown remodel the hepatic metabolome and reduce macrophage foam cell formation and inflammatory activation in high-fat diet-fed ApoE-/- mice?
Does hepatic GPR146 knockdown remodel the hepatic metabolome and reduce macrophage foam cell formation and inflammatory activation in high-fat diet-fed ApoE-/- mice?
Hepatic GPR146 knockdown in ApoE-/- mice alters the liver metabolome and attenuates peritoneal macrophage lipid accumulation and pro-inflammatory M1 polarization, highlighting a potential systemic link between hepatic lipid regulation and atherosclerotic macrophage responses.
Answers are grounded in this paper and cite their sources.
Hepatic GPR146 targeting remains premature for clinical use; leaves open remote macrophage modulation in atherosclerosis models.
Background: GPR146 is a G protein-coupled receptor involved in lipid metabolism and atherosclerosis. However, whether hepatic GPR146 exerts systemic metabolic effects that remotely modulate macrophage function remains unexplored. Methods: Hepatic GPR146 knockdown and negative control groups were established in high-fat diet-fed ApoE−/− mice. Untargeted metabolomics was performed on liver tissues, and peritoneal macrophages were isolated for Oil Red O, BODIPY 493/503, and Filipin staining, as well as RT-qPCR analysis of genes associated with lipid uptake, cholesterol efflux, and polarization markers. Results: Hepatic GPR146 knockdown significantly altered the hepatic metabolome, with arachidonic acid metabolism showing negative enrichment and the ABC transporters pathway showing positive enrichment. Macrophages from shGpr146 mice exhibited markedly reduced lipid accumulation upon ox-LDL stimulation, accompanied by decreased CD36 and SR-A1 mRNA expression, whereas ABCA1 and ABCG1 mRNA levels remained unchanged. Additionally, macrophages from shGpr146 mice showed reduced expression of the M1-associated markers iNOS and IL-1β and increased expression of the M2-associated marker Fizz1. Conclusions: Our findings reveal that hepatic GPR146 knockdown remodels the hepatic metabolome and may attenuate macrophage foam cell formation and pro-inflammatory polarization, suggesting a potential association between hepatic metabolic reprogramming and macrophage responses.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied Atherosclerosis and lipid metabolism in high-fat diet-fed ApoE−/− mice. Hepatic GPR146 knockdown (shGpr146) vs. Negative control was evaluated on Hepatic metabolome profile, macrophage foam cell formation (lipid accumulation), and inflammatory polarization markers. Hepatic GPR146 knockdown in ApoE−/− mice altered hepatic metabolism, reduced macrophage ox-LDL lipid accumulation and CD36/SR-A1 mRNA, and shifted polarization from M1 (iNOS, IL-1β) to M2 (Fizz1).
Synapse has enriched 10 related papers. Consider them for comparative context: